The Current Status of Anti-TNF Therapies for Inflammatory Bowel Disease – A Podcast Series - European Medical Journal

The Current Status of Anti-TNF Therapies for Inflammatory Bowel Disease – A Podcast Series

Gastroenterology

The Series Experts:

Yamile Zabana, MD,
Gastroenterologist in Inflammatory Bowel Diseases Unit Gastroenterology Department, Hospital Universitari Mútua de Terrassa, University of Barcelona, Spain

Expertise in inflammatory Bowel Disease considering varied aspects of management and treatment of Crohn’s disease (CD) and ulcerative colitis (UC), including the management of infections in patients with these conditions.

Shubha Bhat, Pharm.D.
Clinical Pharmacist Specialist – Gastroenterology and Assistant Professor of Medicine, Digestive Disease Institute, Case Western Reserve, Cleveland Clinic Learner College of Medicine, Ohio, USA

Expertise in research focus is on IBD medication access, adoption, and outcomes considering primary care and patient engagement in IBD. She provides medication education, monitors medication outcomes, manages adverse effects, and coordinates health maintenance needs for patients with inflammatory bowel disease.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.